Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests

Arthritis and Rheumatism

Volumn 63, Issue 11, 2011, Pages 3531-3539

  Schreiber, Benjamin E ^a   Valerio, Christopher J ^a   Keir, Gregory J ^b   Handler, Clive ^a   Wells, Athol U ^b   Denton, Christopher P ^c   Coghlan, John G ^a  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CENTROMERE ANTIBODY; SCL 70 ANTIBODY;

ARTICLE; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FORCED VITAL CAPACITY; HEART CATHETERIZATION; HUMAN; LUNG ARTERY PRESSURE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; OXYGEN SATURATION; PATIENT SELECTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULSE OXIMETRY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS;

BLOOD PRESSURE DETERMINATION; CARDIAC CATHETERIZATION; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG; MALE; PREDICTIVE VALUE OF TESTS; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY;

EID: 80155206329     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30535     Document Type: Article

References (20)

1. Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088-93. (Pubitemid 37323574)
2. Nihtyanova SI, Tang EC, Coghlan JG, Wells AU, Black CM, Denton CP,. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. QJM 2010; 103: 109-15.
3. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988; 15: 202-5. (Pubitemid 18073738)
4. Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC), the European Respiratory Society (ERS), the International Society of Heart and Lung Transplantation (ISHLT), Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219-63.
5. Rich S,. Primary pulmonary hypertension: executive summary from the World Symposium on Primary Pulmonary Hypertension. Evian, France: World Health Organization; 1998.
6. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54 Suppl S: S43-54.
7. Hsu VM, Moreyra AE, Wilson AC, Shinnar M, Shindler DM, Wilson JE, et al. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 2008; 35: 458-65. (Pubitemid 351374421)
8. Zissman DA, Ross DJ, Belperio JA, Saggar R, Lynch JP III, Ardehali A, et al. Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med 2007; 101: 2153-9. (Pubitemid 47324243)
9. Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, et al. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum 2008; 58: 284-91.
10. Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM, et al. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum 2009; 60: 569-77.
11. Guazzi M, Arena R,. Pulmonary hypertension with left-sided heart disease. Nat Rev Cardiol 2010; 7: 648-59.
12. Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009; 179: 615-21.
13. Wells AU, Hansell DM, Rubens MB, King AD, Cramer D, Black CM, et al. Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography. Arthritis Rheum 1997; 40: 1229-36. (Pubitemid 27430133)
14. Keir G, Wells AU,. Assessing pulmonary disease and response to therapy: which test? Semin Respir Crit Care Med 2010; 31: 409-18.
15. Arunthari V, Burger CD, Lee AS,. Correlation of pulmonary function variables with hemodynamic measurements in patients with pulmonary arterial hypertension. Clin Respir J 2011; 5: 35-43.
16. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 2009; 53: 1573-619.
17. McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126: 14-34S.
18. Hunzelmann N, Genth E, Krieg T, Meurer M, Melchers I, Moinzadeh P, et al, for the German Network for Systemic Sclerosis. Organ-specific diagnosis in patients with systemic sclerosis: recommendations of the German Network for Systemic Sclerosis (DNSS). Z Rheumatol 2008; 67: 334-40. In German.
19. Proudman SM, Stevens WM, Sahhar J, Celermajer D,. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Intern Med J 2007; 37: 485-94. (Pubitemid 46855082)
20. Meune C, Avouac J, Airo P, Beretta L, Dieude P, Wahbi K, et al. Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. Arthritis Rheum 2011; 63: 2790-6.